Open AccessSulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer’s Disease
Author(s) -
Prayasee Baruah,
Abhinandan Das,
Debojit Paul,
Suman Chakrabarty,
Kripamoy Aguan,
Sivaprasad Mitra
Publication year - 2021
Publication title -
acs pharmacology and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.271
H-Index - 10
ISSN - 2575-9108
DOI - 10.1021/acsptsci.0c00168
Subject(s) - acetylcholinesterase , galantamine , pharmacology , donepezil , ic50 , sulfonylurea , chemistry , drug , acetylcholinesterase inhibitor , non competitive inhibition , medicine , enzyme , diabetes mellitus , biochemistry , endocrinology , disease , dementia , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom